Showing 5571-5580 of 19384 results for "".
Epigenetics in the Environment: An Exploration of Genetics & Chronic Health Conditions
https://reachmd.com/programs/clinicians-roundtable/epigenetics-in-the-environment-an-exploration-of-genetics-chronic-health-conditions/12630/What does the inclusion of epigenetics in medicine mean for patients with chronic health conditions?Value-Based Care: Taking the Pulse of Key Stakeholders in Healthcare
https://reachmd.com/programs/perspectives-ama/value-based-care-taking-the-pulse-of-key-stakeholders-in-healthcare/10789/Amid the recent push towards value-based care, four thought leaders share their takes on its definition, benefits, challenges, and opportunities.Microchimerism and Rheumatoid Arthritis
https://reachmd.com/programs/clinicians-roundtable/microchimerism-and-rheumatoid-arthritis/900/Rheumatoid Arthritis often improves during pregnancy. Why? Truth is stranger than fiction here as it appears that immunologically competent fetal cells leaking into the maternal circulation moderate the maternal immune response to "self."Eating Seafood May Help Lower the Risk of Dementia
https://reachmd.com/programs/the-jama-report/eating-seafood-may-help-lower-risk-dementia/7916/[Read the Article] A new study examined the brains of deceased individuals and found that moderate seafood consumption correlated with lesser Alzheimer disease.Researchers from Rush University Medical Center in Chicago enrolled older people living in public housing and retirement communities in an oFertility Preservation Options for Women
https://reachmd.com/programs/clinicians-roundtable/fertility-preservation-options-for-women/6869/Fertility preservation technologies have become more advanced and more accessible over the past several years. Joining host Dr. Prathima Setty to discuss current options for women to protect their fertility is Dr. Naveed Khan, Reproductive Endocrinology and Infertility Specialist in Leesburg, VA. DrCombination Drug Treatment Reduces Agitation in Patients with Alzheimer's Disease
https://reachmd.com/programs/the-jama-report/combination-drug-treatment-reduces-agitation-patients-alzheimers-disease/7712/[Read the Article] Agitation is common in patients with dementia and can contribute to distress for patients and caregivers and an increased risk of institutionalization. Nonpharmacological interventions are recommended as first-line therapy, but many patients fail to respond, and medications are ofWhy You Need to Start Saving Now
https://reachmd.com/programs/your-money-your-life-financial-advice-for-physicians/why-you-need-start-saving-now/8136/In this video, Jim Hemphill, CERTIFIED FINANCIAL PLANNER™ and co-founder of TGS Financial Advisors, takes a look at the magic and tyranny of compound interest. Understanding the time value of money is a core concept in all economic decision making. Click here to learn more about other financial relaTreating Obesity: Lifelong Strategies from Lifestyle to Pharmacotherapy and Surgery
https://reachmd.com/programs/cme/treating-obesity-lifelong-strategies-from-lifestyle-to-pharmacotherapy-and-surgery-treating-obesity-lifelong-strategies-ffrom-lifestyle-to-pharmacotherapy-and-surgery/35828/Unlock expert insights on obesity as a chronic disease—tackle stigma, manage comorbidities, and optimize long-term care strategies.Hair Loss in Patients With Diverse Skin Tones (Part 2)
https://reachmd.com/programs/practical-dermatology/hair-loss-in-patients-with-diverse-skin-tones-part-2/18195/In this second installment of a two-part episode of The Practical Dermatology Podcast, Brooke Jackson, MD, founder and owner of Skin Wellness Dermatology Associates in Durham, NC, and a dermatologic surgeon and dermatologist, continues the conversation, focusing on different hair textures and stylesAlectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
https://reachmd.com/programs/Audioabstracts/alectinib-vs-crizotinib-in-alk-nsclc-final-alex-data/56343/Long-term results from the ALEX trial reveal how first-line alectinib is reshaping survival expectations in ALK-positive non-small cell lung cancer (ALK+ NSCLC). In this AudioAbstract, hear Ryan Quigley break down the lasting impact of these findings on treatment decisions and patient outcomes.